France
12 Vaccines Approved for Use in France
Protein Subunit
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: ema.europa.eu
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.1
Approved in 38 countries
5 trials in 4 countries
Approval Source: ema.europa.eu
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1
Approved in 35 countries
3 trials in 5 countries
Approval Source: ema.europa.eu
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5
Approved in 33 countries
4 trials in 1 country
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: ema.europa.eu
Inactivated
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5
Approved in 33 countries
2 trials in 1 country
Approval Source: ema.europa.eu
Protein Subunit
Sanofi/GSK
VidPrevtyn Beta
Approved in 30 countries
3 trials in 2 countries
Approval Source: ema.europa.eu
8 in Clinical Trials in France
Protein Subunit
Sanofi/GSK
Recombinant Protein
6 trials in 7 countries
Protein Subunit
Sanofi/GSK
SP/GSK subunit B.1.351 vaccine
3 trials in 2 countries
Protein Subunit
Sanofi/GSK
SP/GSK subunit D614 vaccine
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Protein Subunit
Sanofi/GSK
VidPrevtyn Beta
Approved in 30 countries
3 trials in 2 countries
2 Vaccines with Trials in France are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries
Replicating Viral Vector
Institut Pasteur